The subspecialties provided by the unit are:     

i)                     Vitreoretinal diseases

ii)                   Medical Ophthalmology

iii)                  Uvea

The retina services of this Department have many firsts to its credit, having done pioneering work in vascular angiopathies such as branch retinal vein occlusion, Central serous choroidopathy, and endophthalmitis.

Significant clinical advances have been - the role of silicone oil in endophthalmitis, the role of intravitreal triamcinolone actonide, (IVTA), and intravitreal avastin.

Advances in the management of uveitis, include trials with Retisert implant and a new technique for posterior subtenon injections. Improvements in the management of age related macular degeneration and choroidal neovascular membrane have encompassed trials with intravitreal Avastin, transpupillary thermotherapy, photodynamic therapy and transscleral Diode laser.